发明名称 EML4-ALK FUSION GENE
摘要 <p>The present inventors found that a fusion gene present in some cancer patients is an oncogene. The present invention relates to a polypeptide as a novel fusion protein, a polynucleotide encoding the polypeptide, a vector comprising the polynucleotide, a transformed cell comprising the vector, a method for detecting the fusion protein or polynucleotide, a method for screening a therapeutic agent for cancer, and a therapeutic agent for cancer. Further, the present invention relates kit, primer set, and probe useful in the detection of cancer that is shown to be positive for the fusion gene.</p>
申请公布号 CA2598893(C) 申请公布日期 2012.04.10
申请号 CA20072598893 申请日期 2007.08.24
申请人 ASTELLAS PHARMA INC.;CUREGENE K.K. 发明人 MANO, HIROYUKI;KUROMITSU, SADAO;SHINDO, NOBUAKI;SOGA, TAKATOSHI;FURUTANI, TAKASHI
分类号 C12N15/62;A61K31/506;A61K31/713;A61K48/00;A61P35/00;C07H21/00;C07K14/47;C12N9/12;C12N15/12;C12N15/54;C12N15/63;C12P19/34;C12P21/02;C12Q1/02;C12Q1/68;G01N33/53 主分类号 C12N15/62
代理机构 代理人
主权项
地址